Pharma & Healthcare
Global Infectious Disease Drugs Market Research Report 2024
- Jan 29, 24
- ID: 49819
- Pages: 85
- Figures: 162
- Views: 18
Infectious Disease Drugs are drugs that relieve symptoms, resolve symptoms, or block the route of transmission.
The global Infectious Disease Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Infectious Disease Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease Drugs.
Report Scope
The Infectious Disease Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infectious Disease Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infectious Disease Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Gilead Sciences
Merck & Co.
Pfizer
Sanofi
AbbVie
Shire
Grifols
Johnson & Johnson
Protein Sciences
AstraZeneca
Segment by Type
Antibacterials
Antiviral drugs
Antiparasitic drugs
Antifungal
Others
Segment by Application
HIV
Malaria
Hepatitis
Influenza
HPV
Tuberculosis
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infectious Disease Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Infectious Disease Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Infectious Disease Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease Drugs.
Report Scope
The Infectious Disease Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infectious Disease Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infectious Disease Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Gilead Sciences
Merck & Co.
Pfizer
Sanofi
AbbVie
Shire
Grifols
Johnson & Johnson
Protein Sciences
AstraZeneca
Segment by Type
Antibacterials
Antiviral drugs
Antiparasitic drugs
Antifungal
Others
Segment by Application
HIV
Malaria
Hepatitis
Influenza
HPV
Tuberculosis
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infectious Disease Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Disease Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antibacterials
1.2.3 Antiviral drugs
1.2.4 Antiparasitic drugs
1.2.5 Antifungal
1.2.6 Others
1.3 Market by Application
1.3.1 Global Infectious Disease Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 HIV
1.3.3 Malaria
1.3.4 Hepatitis
1.3.5 Influenza
1.3.6 HPV
1.3.7 Tuberculosis
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infectious Disease Drugs Market Perspective (2019-2030)
2.2 Infectious Disease Drugs Growth Trends by Region
2.2.1 Global Infectious Disease Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Infectious Disease Drugs Historic Market Size by Region (2019-2024)
2.2.3 Infectious Disease Drugs Forecasted Market Size by Region (2025-2030)
2.3 Infectious Disease Drugs Market Dynamics
2.3.1 Infectious Disease Drugs Industry Trends
2.3.2 Infectious Disease Drugs Market Drivers
2.3.3 Infectious Disease Drugs Market Challenges
2.3.4 Infectious Disease Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease Drugs Players by Revenue
3.1.1 Global Top Infectious Disease Drugs Players by Revenue (2019-2024)
3.1.2 Global Infectious Disease Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Infectious Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Infectious Disease Drugs Revenue
3.4 Global Infectious Disease Drugs Market Concentration Ratio
3.4.1 Global Infectious Disease Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Drugs Revenue in 2023
3.5 Infectious Disease Drugs Key Players Head office and Area Served
3.6 Key Players Infectious Disease Drugs Product Solution and Service
3.7 Date of Enter into Infectious Disease Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease Drugs Breakdown Data by Type
4.1 Global Infectious Disease Drugs Historic Market Size by Type (2019-2024)
4.2 Global Infectious Disease Drugs Forecasted Market Size by Type (2025-2030)
5 Infectious Disease Drugs Breakdown Data by Application
5.1 Global Infectious Disease Drugs Historic Market Size by Application (2019-2024)
5.2 Global Infectious Disease Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Infectious Disease Drugs Market Size (2019-2030)
6.2 North America Infectious Disease Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Infectious Disease Drugs Market Size by Country (2019-2024)
6.4 North America Infectious Disease Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Infectious Disease Drugs Market Size (2019-2030)
7.2 Europe Infectious Disease Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Infectious Disease Drugs Market Size by Country (2019-2024)
7.4 Europe Infectious Disease Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease Drugs Market Size (2019-2030)
8.2 Asia-Pacific Infectious Disease Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Infectious Disease Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Infectious Disease Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Infectious Disease Drugs Market Size (2019-2030)
9.2 Latin America Infectious Disease Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Infectious Disease Drugs Market Size by Country (2019-2024)
9.4 Latin America Infectious Disease Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease Drugs Market Size (2019-2030)
10.2 Middle East & Africa Infectious Disease Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Infectious Disease Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Infectious Disease Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Infectious Disease Drugs Introduction
11.1.4 GlaxoSmithKline Revenue in Infectious Disease Drugs Business (2019-2024)
11.1.5 GlaxoSmithKline Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Detail
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Infectious Disease Drugs Introduction
11.2.4 Gilead Sciences Revenue in Infectious Disease Drugs Business (2019-2024)
11.2.5 Gilead Sciences Recent Development
11.3 Merck & Co.
11.3.1 Merck & Co. Company Detail
11.3.2 Merck & Co. Business Overview
11.3.3 Merck & Co. Infectious Disease Drugs Introduction
11.3.4 Merck & Co. Revenue in Infectious Disease Drugs Business (2019-2024)
11.3.5 Merck & Co. Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Infectious Disease Drugs Introduction
11.4.4 Pfizer Revenue in Infectious Disease Drugs Business (2019-2024)
11.4.5 Pfizer Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Infectious Disease Drugs Introduction
11.5.4 Sanofi Revenue in Infectious Disease Drugs Business (2019-2024)
11.5.5 Sanofi Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Detail
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Infectious Disease Drugs Introduction
11.6.4 AbbVie Revenue in Infectious Disease Drugs Business (2019-2024)
11.6.5 AbbVie Recent Development
11.7 Shire
11.7.1 Shire Company Detail
11.7.2 Shire Business Overview
11.7.3 Shire Infectious Disease Drugs Introduction
11.7.4 Shire Revenue in Infectious Disease Drugs Business (2019-2024)
11.7.5 Shire Recent Development
11.8 Grifols
11.8.1 Grifols Company Detail
11.8.2 Grifols Business Overview
11.8.3 Grifols Infectious Disease Drugs Introduction
11.8.4 Grifols Revenue in Infectious Disease Drugs Business (2019-2024)
11.8.5 Grifols Recent Development
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Company Detail
11.9.2 Johnson & Johnson Business Overview
11.9.3 Johnson & Johnson Infectious Disease Drugs Introduction
11.9.4 Johnson & Johnson Revenue in Infectious Disease Drugs Business (2019-2024)
11.9.5 Johnson & Johnson Recent Development
11.10 Protein Sciences
11.10.1 Protein Sciences Company Detail
11.10.2 Protein Sciences Business Overview
11.10.3 Protein Sciences Infectious Disease Drugs Introduction
11.10.4 Protein Sciences Revenue in Infectious Disease Drugs Business (2019-2024)
11.10.5 Protein Sciences Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Detail
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Infectious Disease Drugs Introduction
11.11.4 AstraZeneca Revenue in Infectious Disease Drugs Business (2019-2024)
11.11.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Disease Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antibacterials
1.2.3 Antiviral drugs
1.2.4 Antiparasitic drugs
1.2.5 Antifungal
1.2.6 Others
1.3 Market by Application
1.3.1 Global Infectious Disease Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 HIV
1.3.3 Malaria
1.3.4 Hepatitis
1.3.5 Influenza
1.3.6 HPV
1.3.7 Tuberculosis
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infectious Disease Drugs Market Perspective (2019-2030)
2.2 Infectious Disease Drugs Growth Trends by Region
2.2.1 Global Infectious Disease Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Infectious Disease Drugs Historic Market Size by Region (2019-2024)
2.2.3 Infectious Disease Drugs Forecasted Market Size by Region (2025-2030)
2.3 Infectious Disease Drugs Market Dynamics
2.3.1 Infectious Disease Drugs Industry Trends
2.3.2 Infectious Disease Drugs Market Drivers
2.3.3 Infectious Disease Drugs Market Challenges
2.3.4 Infectious Disease Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease Drugs Players by Revenue
3.1.1 Global Top Infectious Disease Drugs Players by Revenue (2019-2024)
3.1.2 Global Infectious Disease Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Infectious Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Infectious Disease Drugs Revenue
3.4 Global Infectious Disease Drugs Market Concentration Ratio
3.4.1 Global Infectious Disease Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Drugs Revenue in 2023
3.5 Infectious Disease Drugs Key Players Head office and Area Served
3.6 Key Players Infectious Disease Drugs Product Solution and Service
3.7 Date of Enter into Infectious Disease Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease Drugs Breakdown Data by Type
4.1 Global Infectious Disease Drugs Historic Market Size by Type (2019-2024)
4.2 Global Infectious Disease Drugs Forecasted Market Size by Type (2025-2030)
5 Infectious Disease Drugs Breakdown Data by Application
5.1 Global Infectious Disease Drugs Historic Market Size by Application (2019-2024)
5.2 Global Infectious Disease Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Infectious Disease Drugs Market Size (2019-2030)
6.2 North America Infectious Disease Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Infectious Disease Drugs Market Size by Country (2019-2024)
6.4 North America Infectious Disease Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Infectious Disease Drugs Market Size (2019-2030)
7.2 Europe Infectious Disease Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Infectious Disease Drugs Market Size by Country (2019-2024)
7.4 Europe Infectious Disease Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease Drugs Market Size (2019-2030)
8.2 Asia-Pacific Infectious Disease Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Infectious Disease Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Infectious Disease Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Infectious Disease Drugs Market Size (2019-2030)
9.2 Latin America Infectious Disease Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Infectious Disease Drugs Market Size by Country (2019-2024)
9.4 Latin America Infectious Disease Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease Drugs Market Size (2019-2030)
10.2 Middle East & Africa Infectious Disease Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Infectious Disease Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Infectious Disease Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Infectious Disease Drugs Introduction
11.1.4 GlaxoSmithKline Revenue in Infectious Disease Drugs Business (2019-2024)
11.1.5 GlaxoSmithKline Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Detail
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Infectious Disease Drugs Introduction
11.2.4 Gilead Sciences Revenue in Infectious Disease Drugs Business (2019-2024)
11.2.5 Gilead Sciences Recent Development
11.3 Merck & Co.
11.3.1 Merck & Co. Company Detail
11.3.2 Merck & Co. Business Overview
11.3.3 Merck & Co. Infectious Disease Drugs Introduction
11.3.4 Merck & Co. Revenue in Infectious Disease Drugs Business (2019-2024)
11.3.5 Merck & Co. Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Infectious Disease Drugs Introduction
11.4.4 Pfizer Revenue in Infectious Disease Drugs Business (2019-2024)
11.4.5 Pfizer Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Infectious Disease Drugs Introduction
11.5.4 Sanofi Revenue in Infectious Disease Drugs Business (2019-2024)
11.5.5 Sanofi Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Detail
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Infectious Disease Drugs Introduction
11.6.4 AbbVie Revenue in Infectious Disease Drugs Business (2019-2024)
11.6.5 AbbVie Recent Development
11.7 Shire
11.7.1 Shire Company Detail
11.7.2 Shire Business Overview
11.7.3 Shire Infectious Disease Drugs Introduction
11.7.4 Shire Revenue in Infectious Disease Drugs Business (2019-2024)
11.7.5 Shire Recent Development
11.8 Grifols
11.8.1 Grifols Company Detail
11.8.2 Grifols Business Overview
11.8.3 Grifols Infectious Disease Drugs Introduction
11.8.4 Grifols Revenue in Infectious Disease Drugs Business (2019-2024)
11.8.5 Grifols Recent Development
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Company Detail
11.9.2 Johnson & Johnson Business Overview
11.9.3 Johnson & Johnson Infectious Disease Drugs Introduction
11.9.4 Johnson & Johnson Revenue in Infectious Disease Drugs Business (2019-2024)
11.9.5 Johnson & Johnson Recent Development
11.10 Protein Sciences
11.10.1 Protein Sciences Company Detail
11.10.2 Protein Sciences Business Overview
11.10.3 Protein Sciences Infectious Disease Drugs Introduction
11.10.4 Protein Sciences Revenue in Infectious Disease Drugs Business (2019-2024)
11.10.5 Protein Sciences Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Detail
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Infectious Disease Drugs Introduction
11.11.4 AstraZeneca Revenue in Infectious Disease Drugs Business (2019-2024)
11.11.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Infectious Disease Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Antibacterials
Table 3. Key Players of Antiviral drugs
Table 4. Key Players of Antiparasitic drugs
Table 5. Key Players of Antifungal
Table 6. Key Players of Others
Table 7. Global Infectious Disease Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Infectious Disease Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Infectious Disease Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Infectious Disease Drugs Market Share by Region (2019-2024)
Table 11. Global Infectious Disease Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Infectious Disease Drugs Market Share by Region (2025-2030)
Table 13. Infectious Disease Drugs Market Trends
Table 14. Infectious Disease Drugs Market Drivers
Table 15. Infectious Disease Drugs Market Challenges
Table 16. Infectious Disease Drugs Market Restraints
Table 17. Global Infectious Disease Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Infectious Disease Drugs Market Share by Players (2019-2024)
Table 19. Global Top Infectious Disease Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Drugs as of 2023)
Table 20. Ranking of Global Top Infectious Disease Drugs Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Infectious Disease Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Infectious Disease Drugs Product Solution and Service
Table 24. Date of Enter into Infectious Disease Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Infectious Disease Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Infectious Disease Drugs Revenue Market Share by Type (2019-2024)
Table 28. Global Infectious Disease Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Infectious Disease Drugs Revenue Market Share by Type (2025-2030)
Table 30. Global Infectious Disease Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Infectious Disease Drugs Revenue Market Share by Application (2019-2024)
Table 32. Global Infectious Disease Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Infectious Disease Drugs Revenue Market Share by Application (2025-2030)
Table 34. North America Infectious Disease Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Infectious Disease Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Infectious Disease Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Infectious Disease Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Infectious Disease Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Infectious Disease Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Infectious Disease Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Infectious Disease Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Infectious Disease Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Infectious Disease Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Infectious Disease Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Infectious Disease Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Infectious Disease Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Infectious Disease Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Infectious Disease Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 49. GlaxoSmithKline Company Detail
Table 50. GlaxoSmithKline Business Overview
Table 51. GlaxoSmithKline Infectious Disease Drugs Product
Table 52. GlaxoSmithKline Revenue in Infectious Disease Drugs Business (2019-2024) & (US$ Million)
Table 53. GlaxoSmithKline Recent Development
Table 54. Gilead Sciences Company Detail
Table 55. Gilead Sciences Business Overview
Table 56. Gilead Sciences Infectious Disease Drugs Product
Table 57. Gilead Sciences Revenue in Infectious Disease Drugs Business (2019-2024) & (US$ Million)
Table 58. Gilead Sciences Recent Development
Table 59. Merck & Co. Company Detail
Table 60. Merck & Co. Business Overview
Table 61. Merck & Co. Infectious Disease Drugs Product
Table 62. Merck & Co. Revenue in Infectious Disease Drugs Business (2019-2024) & (US$ Million)
Table 63. Merck & Co. Recent Development
Table 64. Pfizer Company Detail
Table 65. Pfizer Business Overview
Table 66. Pfizer Infectious Disease Drugs Product
Table 67. Pfizer Revenue in Infectious Disease Drugs Business (2019-2024) & (US$ Million)
Table 68. Pfizer Recent Development
Table 69. Sanofi Company Detail
Table 70. Sanofi Business Overview
Table 71. Sanofi Infectious Disease Drugs Product
Table 72. Sanofi Revenue in Infectious Disease Drugs Business (2019-2024) & (US$ Million)
Table 73. Sanofi Recent Development
Table 74. AbbVie Company Detail
Table 75. AbbVie Business Overview
Table 76. AbbVie Infectious Disease Drugs Product
Table 77. AbbVie Revenue in Infectious Disease Drugs Business (2019-2024) & (US$ Million)
Table 78. AbbVie Recent Development
Table 79. Shire Company Detail
Table 80. Shire Business Overview
Table 81. Shire Infectious Disease Drugs Product
Table 82. Shire Revenue in Infectious Disease Drugs Business (2019-2024) & (US$ Million)
Table 83. Shire Recent Development
Table 84. Grifols Company Detail
Table 85. Grifols Business Overview
Table 86. Grifols Infectious Disease Drugs Product
Table 87. Grifols Revenue in Infectious Disease Drugs Business (2019-2024) & (US$ Million)
Table 88. Grifols Recent Development
Table 89. Johnson & Johnson Company Detail
Table 90. Johnson & Johnson Business Overview
Table 91. Johnson & Johnson Infectious Disease Drugs Product
Table 92. Johnson & Johnson Revenue in Infectious Disease Drugs Business (2019-2024) & (US$ Million)
Table 93. Johnson & Johnson Recent Development
Table 94. Protein Sciences Company Detail
Table 95. Protein Sciences Business Overview
Table 96. Protein Sciences Infectious Disease Drugs Product
Table 97. Protein Sciences Revenue in Infectious Disease Drugs Business (2019-2024) & (US$ Million)
Table 98. Protein Sciences Recent Development
Table 99. AstraZeneca Company Detail
Table 100. AstraZeneca Business Overview
Table 101. AstraZeneca Infectious Disease Drugs Product
Table 102. AstraZeneca Revenue in Infectious Disease Drugs Business (2019-2024) & (US$ Million)
Table 103. AstraZeneca Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infectious Disease Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Infectious Disease Drugs Market Share by Type: 2023 VS 2030
Figure 3. Antibacterials Features
Figure 4. Antiviral drugs Features
Figure 5. Antiparasitic drugs Features
Figure 6. Antifungal Features
Figure 7. Others Features
Figure 8. Global Infectious Disease Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Infectious Disease Drugs Market Share by Application: 2023 VS 2030
Figure 10. HIV Case Studies
Figure 11. Malaria Case Studies
Figure 12. Hepatitis Case Studies
Figure 13. Influenza Case Studies
Figure 14. HPV Case Studies
Figure 15. Tuberculosis Case Studies
Figure 16. Others Case Studies
Figure 17. Infectious Disease Drugs Report Years Considered
Figure 18. Global Infectious Disease Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 19. Global Infectious Disease Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 20. Global Infectious Disease Drugs Market Share by Region: 2023 VS 2030
Figure 21. Global Infectious Disease Drugs Market Share by Players in 2023
Figure 22. Global Top Infectious Disease Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Drugs as of 2023)
Figure 23. The Top 10 and 5 Players Market Share by Infectious Disease Drugs Revenue in 2023
Figure 24. North America Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. North America Infectious Disease Drugs Market Share by Country (2019-2030)
Figure 26. United States Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Canada Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Europe Infectious Disease Drugs Market Share by Country (2019-2030)
Figure 30. Germany Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. France Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. U.K. Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Italy Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Russia Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Nordic Countries Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Asia-Pacific Infectious Disease Drugs Market Share by Region (2019-2030)
Figure 38. China Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Japan Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. South Korea Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. India Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Australia Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Latin America Infectious Disease Drugs Market Share by Country (2019-2030)
Figure 46. Mexico Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Brazil Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Infectious Disease Drugs Market Share by Country (2019-2030)
Figure 50. Turkey Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. GlaxoSmithKline Revenue Growth Rate in Infectious Disease Drugs Business (2019-2024)
Figure 53. Gilead Sciences Revenue Growth Rate in Infectious Disease Drugs Business (2019-2024)
Figure 54. Merck & Co. Revenue Growth Rate in Infectious Disease Drugs Business (2019-2024)
Figure 55. Pfizer Revenue Growth Rate in Infectious Disease Drugs Business (2019-2024)
Figure 56. Sanofi Revenue Growth Rate in Infectious Disease Drugs Business (2019-2024)
Figure 57. AbbVie Revenue Growth Rate in Infectious Disease Drugs Business (2019-2024)
Figure 58. Shire Revenue Growth Rate in Infectious Disease Drugs Business (2019-2024)
Figure 59. Grifols Revenue Growth Rate in Infectious Disease Drugs Business (2019-2024)
Figure 60. Johnson & Johnson Revenue Growth Rate in Infectious Disease Drugs Business (2019-2024)
Figure 61. Protein Sciences Revenue Growth Rate in Infectious Disease Drugs Business (2019-2024)
Figure 62. AstraZeneca Revenue Growth Rate in Infectious Disease Drugs Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Infectious Disease Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Antibacterials
Table 3. Key Players of Antiviral drugs
Table 4. Key Players of Antiparasitic drugs
Table 5. Key Players of Antifungal
Table 6. Key Players of Others
Table 7. Global Infectious Disease Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Infectious Disease Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Infectious Disease Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Infectious Disease Drugs Market Share by Region (2019-2024)
Table 11. Global Infectious Disease Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Infectious Disease Drugs Market Share by Region (2025-2030)
Table 13. Infectious Disease Drugs Market Trends
Table 14. Infectious Disease Drugs Market Drivers
Table 15. Infectious Disease Drugs Market Challenges
Table 16. Infectious Disease Drugs Market Restraints
Table 17. Global Infectious Disease Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Infectious Disease Drugs Market Share by Players (2019-2024)
Table 19. Global Top Infectious Disease Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Drugs as of 2023)
Table 20. Ranking of Global Top Infectious Disease Drugs Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Infectious Disease Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Infectious Disease Drugs Product Solution and Service
Table 24. Date of Enter into Infectious Disease Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Infectious Disease Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Infectious Disease Drugs Revenue Market Share by Type (2019-2024)
Table 28. Global Infectious Disease Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Infectious Disease Drugs Revenue Market Share by Type (2025-2030)
Table 30. Global Infectious Disease Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Infectious Disease Drugs Revenue Market Share by Application (2019-2024)
Table 32. Global Infectious Disease Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Infectious Disease Drugs Revenue Market Share by Application (2025-2030)
Table 34. North America Infectious Disease Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Infectious Disease Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Infectious Disease Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Infectious Disease Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Infectious Disease Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Infectious Disease Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Infectious Disease Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Infectious Disease Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Infectious Disease Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Infectious Disease Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Infectious Disease Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Infectious Disease Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Infectious Disease Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Infectious Disease Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Infectious Disease Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 49. GlaxoSmithKline Company Detail
Table 50. GlaxoSmithKline Business Overview
Table 51. GlaxoSmithKline Infectious Disease Drugs Product
Table 52. GlaxoSmithKline Revenue in Infectious Disease Drugs Business (2019-2024) & (US$ Million)
Table 53. GlaxoSmithKline Recent Development
Table 54. Gilead Sciences Company Detail
Table 55. Gilead Sciences Business Overview
Table 56. Gilead Sciences Infectious Disease Drugs Product
Table 57. Gilead Sciences Revenue in Infectious Disease Drugs Business (2019-2024) & (US$ Million)
Table 58. Gilead Sciences Recent Development
Table 59. Merck & Co. Company Detail
Table 60. Merck & Co. Business Overview
Table 61. Merck & Co. Infectious Disease Drugs Product
Table 62. Merck & Co. Revenue in Infectious Disease Drugs Business (2019-2024) & (US$ Million)
Table 63. Merck & Co. Recent Development
Table 64. Pfizer Company Detail
Table 65. Pfizer Business Overview
Table 66. Pfizer Infectious Disease Drugs Product
Table 67. Pfizer Revenue in Infectious Disease Drugs Business (2019-2024) & (US$ Million)
Table 68. Pfizer Recent Development
Table 69. Sanofi Company Detail
Table 70. Sanofi Business Overview
Table 71. Sanofi Infectious Disease Drugs Product
Table 72. Sanofi Revenue in Infectious Disease Drugs Business (2019-2024) & (US$ Million)
Table 73. Sanofi Recent Development
Table 74. AbbVie Company Detail
Table 75. AbbVie Business Overview
Table 76. AbbVie Infectious Disease Drugs Product
Table 77. AbbVie Revenue in Infectious Disease Drugs Business (2019-2024) & (US$ Million)
Table 78. AbbVie Recent Development
Table 79. Shire Company Detail
Table 80. Shire Business Overview
Table 81. Shire Infectious Disease Drugs Product
Table 82. Shire Revenue in Infectious Disease Drugs Business (2019-2024) & (US$ Million)
Table 83. Shire Recent Development
Table 84. Grifols Company Detail
Table 85. Grifols Business Overview
Table 86. Grifols Infectious Disease Drugs Product
Table 87. Grifols Revenue in Infectious Disease Drugs Business (2019-2024) & (US$ Million)
Table 88. Grifols Recent Development
Table 89. Johnson & Johnson Company Detail
Table 90. Johnson & Johnson Business Overview
Table 91. Johnson & Johnson Infectious Disease Drugs Product
Table 92. Johnson & Johnson Revenue in Infectious Disease Drugs Business (2019-2024) & (US$ Million)
Table 93. Johnson & Johnson Recent Development
Table 94. Protein Sciences Company Detail
Table 95. Protein Sciences Business Overview
Table 96. Protein Sciences Infectious Disease Drugs Product
Table 97. Protein Sciences Revenue in Infectious Disease Drugs Business (2019-2024) & (US$ Million)
Table 98. Protein Sciences Recent Development
Table 99. AstraZeneca Company Detail
Table 100. AstraZeneca Business Overview
Table 101. AstraZeneca Infectious Disease Drugs Product
Table 102. AstraZeneca Revenue in Infectious Disease Drugs Business (2019-2024) & (US$ Million)
Table 103. AstraZeneca Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infectious Disease Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Infectious Disease Drugs Market Share by Type: 2023 VS 2030
Figure 3. Antibacterials Features
Figure 4. Antiviral drugs Features
Figure 5. Antiparasitic drugs Features
Figure 6. Antifungal Features
Figure 7. Others Features
Figure 8. Global Infectious Disease Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Infectious Disease Drugs Market Share by Application: 2023 VS 2030
Figure 10. HIV Case Studies
Figure 11. Malaria Case Studies
Figure 12. Hepatitis Case Studies
Figure 13. Influenza Case Studies
Figure 14. HPV Case Studies
Figure 15. Tuberculosis Case Studies
Figure 16. Others Case Studies
Figure 17. Infectious Disease Drugs Report Years Considered
Figure 18. Global Infectious Disease Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 19. Global Infectious Disease Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 20. Global Infectious Disease Drugs Market Share by Region: 2023 VS 2030
Figure 21. Global Infectious Disease Drugs Market Share by Players in 2023
Figure 22. Global Top Infectious Disease Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Drugs as of 2023)
Figure 23. The Top 10 and 5 Players Market Share by Infectious Disease Drugs Revenue in 2023
Figure 24. North America Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. North America Infectious Disease Drugs Market Share by Country (2019-2030)
Figure 26. United States Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Canada Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Europe Infectious Disease Drugs Market Share by Country (2019-2030)
Figure 30. Germany Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. France Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. U.K. Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Italy Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Russia Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Nordic Countries Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Asia-Pacific Infectious Disease Drugs Market Share by Region (2019-2030)
Figure 38. China Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Japan Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. South Korea Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. India Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Australia Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Latin America Infectious Disease Drugs Market Share by Country (2019-2030)
Figure 46. Mexico Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Brazil Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Infectious Disease Drugs Market Share by Country (2019-2030)
Figure 50. Turkey Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Infectious Disease Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. GlaxoSmithKline Revenue Growth Rate in Infectious Disease Drugs Business (2019-2024)
Figure 53. Gilead Sciences Revenue Growth Rate in Infectious Disease Drugs Business (2019-2024)
Figure 54. Merck & Co. Revenue Growth Rate in Infectious Disease Drugs Business (2019-2024)
Figure 55. Pfizer Revenue Growth Rate in Infectious Disease Drugs Business (2019-2024)
Figure 56. Sanofi Revenue Growth Rate in Infectious Disease Drugs Business (2019-2024)
Figure 57. AbbVie Revenue Growth Rate in Infectious Disease Drugs Business (2019-2024)
Figure 58. Shire Revenue Growth Rate in Infectious Disease Drugs Business (2019-2024)
Figure 59. Grifols Revenue Growth Rate in Infectious Disease Drugs Business (2019-2024)
Figure 60. Johnson & Johnson Revenue Growth Rate in Infectious Disease Drugs Business (2019-2024)
Figure 61. Protein Sciences Revenue Growth Rate in Infectious Disease Drugs Business (2019-2024)
Figure 62. AstraZeneca Revenue Growth Rate in Infectious Disease Drugs Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232